|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/12/19 Actinium Pharmaceuticals, Inc. 10-Q 9/30/19 40:2.3M Edgar Agents LLC/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 346K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 19K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 19K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 15K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 15K
25: R1 Document and Entity Information HTML 48K
38: R2 Consolidated Balance Sheets (Unaudited) HTML 87K
33: R3 Consolidated Balance Sheets (Unaudited) HTML 36K
(Parenthetical)
14: R4 Consolidated Statements of Operations (Unaudited) HTML 50K
24: R5 Consolidated Statement of Changes in Stockholders' HTML 64K
Equity
37: R6 Consolidated Statements of Cash Flows (Unaudited) HTML 74K
32: R7 Description of Business and Summary of Significant HTML 50K
Accounting Policies
15: R8 Commitments and Contingencies HTML 26K
23: R9 Leases HTML 34K
29: R10 Equity HTML 38K
35: R11 Description of Business and Summary of Significant HTML 84K
Accounting Policies (Policies)
21: R12 Description of Business and Summary of Significant HTML 25K
Accounting Policies (Tables)
12: R13 Leases (Tables) HTML 36K
30: R14 Equity (Tables) HTML 31K
36: R15 Description of Business and Summary of Significant HTML 27K
Accounting Policies (Details)
22: R16 Description of Business and Summary of Significant HTML 22K
Accounting Policies (Details 1)
13: R17 Description of Business and Summary of Significant HTML 27K
Accounting Policies (Details Textual)
31: R18 Commitments and Contingencies (Details Textual) HTML 36K
34: R19 Leases (Details) HTML 25K
19: R20 Leases (Details 1) HTML 27K
16: R21 Leases (Details 2) HTML 18K
27: R22 Leases (Details 3) HTML 18K
40: R23 Leases (Details 4) HTML 31K
20: R24 Leases (Details Textual) HTML 27K
17: R25 Equity (Details) HTML 70K
28: R26 Equity (Details Textual) HTML 87K
39: XML IDEA XML File -- Filing Summary XML 64K
18: EXCEL IDEA Workbook of Financial Reports XLSX 34K
6: EX-101.INS XBRL Instance -- atnm-20190930 XML 524K
8: EX-101.CAL XBRL Calculations -- atnm-20190930_cal XML 95K
9: EX-101.DEF XBRL Definitions -- atnm-20190930_def XML 274K
10: EX-101.LAB XBRL Labels -- atnm-20190930_lab XML 671K
11: EX-101.PRE XBRL Presentations -- atnm-20190930_pre XML 444K
7: EX-101.SCH XBRL Schema -- atnm-20190930 XSD 111K
26: ZIP XBRL Zipped Folder -- 0001213900-19-022937-xbrl Zip 74K
Exhibit 31.2
CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
I, Steve O’Loughlin, certify that:
1. I have reviewed this Form 10-Q of Actinium Pharmaceuticals, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods present in this report;
4. The Registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financing reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The Registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involved management or other employees who have a significant role in the registrant’s internal control over financial reporting.
| Date: November 12, 2019 | ||
| By: | /s/ Steve O’Loughlin | |
| Steve O’Loughlin | ||
| Principal Financial Officer | ||
| (Duly Authorized Officer and Principal Financial and Accounting Officer) | ||
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 11/12/19 | None on these Dates | ||
| For Period end: | 9/30/19 | |||
| List all Filings | ||||